1. Articles in category: Other Business News

    1081-1104 of 1187 « 1 2 ... 43 44 45 46 47 48 49 50 »
    1. NineSigma, representing a global device manufacturer, invites proposals for the development of a low cost tunable light source for optical coherence reflectometry.

      NineSigma, representing a global device manufacturer, invites proposals for the development of a low cost tunable light source for optical coherence reflectometry.
      NineSigma, representing a global device manufacturer, invites proposals for the development of a low cost tunable light source for optical coherence reflectometry. The successful technology must provide a cost efficient swept source module for optical coherence domain reflectometry. The purchase of a working prototype is the preferred solution but final development of a mature concept is possible.
      Read Full Article
    2. Cardiac imaging and OCT's legal mess

      "Word is getting out” about imaging tools that enable more precise guidance during heart surgery, said Volcano Corp. VP Joe Burnett, referring to the increased number of imaging-related presentations at the recent American College of Cardiology (ACC) Annual Meeting 2009.) Speaking at the conference, former ACC President Pamela Douglas, M.D. said that imaging is growing faster than all other procedures, services and diagnostic tests
      Read Full Article
    3. Lantis Files 15(c) 2-11 With Finra to Obtain Listing On OTC Bulletin Board

      DENVILLE, N.J., April 1, 2009 (GLOBE NEWSWIRE) -- Lantis Laser Inc. (Pink Sheets:LLSR) (http://www.lantislaser.com), announced today that it has filed a 15(c) 2-11 with FINRA to obtain a quotation on the OTC Bulletin Board. Stan Baron, President & CEO, pointed out that being a fully reporting company will provide the transparency and credibility that investors require in today's economic environment. Lantis filed an S-1 with the SEC which was deemed effective on February 17, 2009.
      Read Full Article
    4. Volcano Announces Schedule of Events at the ACC 2009, Integration into Indec and Medis Software Platforms

      Volcano Announces Schedule of Events at the ACC 2009, Integration into Indec and Medis Software Platforms
      March 27, 2009 -- San Diego -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today announced its presence at the 58th Annual Scientific Sessions of the American College of Cardiology (ACC) conference in Orlando, FL, to be held from March 29th to 31st, 2009. Joe Burnett, Vice President of Marketing at Volcano commented, "Three years ago, you could flip through the ACC program and see a couple of presentations on intravascular assessment using IVUS or FFR. This year, there are more than 50 presentations ...
      Read Full Article
    5. Medical venture - Michelson Diagnostics

      Medical venture - Michelson Diagnostics
      Orpington-based medical-imaging firm Michelson Diagnostics (MDL) has raised more than £350k from a consortium of investors from the London Business Angels (LBA) network. The money will be used to support multi-centre clinical trials of its new hand-held multi-beam Optical Coherence Tomography (OCT) imaging probe, which the company plans to launch in May or June this year.
      Read Full Article
    6. Medical Venture - Michelson Diagnostics (MDL)

      Orpington-based medical-imaging firm Michelson Diagnostics (MDL) has raised more than £350k from a consortium of investors from the London Business Angels (LBA) network. The money will be used to support multi-centre clinical trials of its new hand-held multi-beam Optical Coherence Tomography (OCT) imaging probe, which the company plans to launch in May or June this year. The money will also support international commercial growth. MDL received early-stage funding of £600k in October 2007 and a further £600k in July 2008, in rounds led by London Seed Capital with Catapult Venture Managers and London Business Angels.
      Read Full Article
    7. Lantis Signs Exclusive Rights in Dentistry for Novel Light-Based Diagnostic Screening Technology

      Near-infrared Transillumination Imaging Provides More Detailed Images Than X-ray. DENVILLE, N.J., Mar 17, 2009 (GlobeNewswire via COMTEX) -- Lantis Laser Inc. (Pink Sheets:LLSR) ( http://www.lantislaser.com) today announced that it has signed an exclusive Agreement for the field of human and animal dentistry with the Regents of the University of California for a light-based technology referred to as "Near-infrared Transillumination Imaging of Early Dental Decay." The technology ("NIR Imaging") is the subject of a PCT patent pending application and was researched and developed over the past five years under the direction of Daniel Fried, PhD, a professor of ...
      Read Full Article
    8. Lantis Signs Exclusive Rights in Dentistry for Novel Light-Based Diagnostic Screening Technology

      Lantis Signs Exclusive Rights in Dentistry for Novel Light-Based Diagnostic Screening Technology
      DENVILLE, N.J., March 17, 2009 (GLOBE NEWSWIRE) -- Lantis Laser Inc. (Other OTC:LLSR.PK - News) (http://www.lantislaser.com) today announced that it has signed an exclusive Agreement for the field of human and animal dentistry with the Regents of the University of California for a light-based technology referred to as ``Near-infrared Transillumination Imaging of Early Dental Decay.'' The technology (``NIR Imaging'') is the subject of a PCT patent pending application and was researched and developed over the past five years under the direction of Daniel Fried, PhD, a professor of Biomaterials and Bioengineering in the Department of Preventive ...
      Read Full Article
    9. Lightlab Imaging, Axsun Technologies, and Volcano Corporation in Legal Dispute

      Lightlab Imaging, Axsun Technologies, and Volcano Corporation in Legal Dispute
      Volcano Corporation's recent Securities and Exchange Commission 10-k filing announced a suit by Lightlab Imaging against Axsun Technologies and Volcano Corporation. Some background information that may be relevant to this court case: On January 7, 2009 Lightlab Imaging filed suit against Axsun Technologies and Volcano Corporation in the Business Litigation Section of the Superior Court of Massachusetts. On December 10, 2007, Volcano, a leading supplier in Intravascular Ultrasound (IVUS) equipment acquired startup company CardioSpectra for ~$55M ($25M plus an additional ~$30M earnout). According to the press release, "CardioSpectra's unique OCT imaging system is expected to complement Volcano's ...
      Read Full Article
    10. Volcano & Axsun Sued by Lightlab Imaging

      Volcano & Axsun Sued by Lightlab Imaging
      On January 7, 2009, LightLab Imaging Inc., or LightLab, filed a complaint against Volcano and its wholly-owned subsidiary, Axsun, in the Superior Court of Massachusetts, Suffolk County, seeking injunctive relief and unspecified damages. LightLab’s complaint alleges that Volcano interfered with LightLab’s development and supply agreement with Axsun and its advantageous business relationship with Axsun, engaged in unfair competition, engaged in unfair or deceptive acts or practices and engaged in misappropriation and wrongful use of LightLab’s confidential information and trade secrets. LightLab’s complaint alleges that Axsun breached its development and supply agreement with LightLab, breached the implied ...
      Read Full Article
    11. Lantis Laser CEO to Appear On AOL Finance Small Cap Show Produced by Agoracom

      DENVILLE, N.J., March 11, 2009 (GLOBE NEWSWIRE) -- Lantis Laser Inc. (Pink Sheets:LLSR) (http://www.lantislaser.com), announced today that its President & CEO, Mr. Stan Baron, can be heard all this week on the AOL Small Cap Show produced by AGORACOM Investor Relations.
      Read Full Article
    12. Lantis Laser CEO to Appear On AOL Finance Small Cap Show Produced by Agoracom

      Lantis Laser CEO to Appear On AOL Finance Small Cap Show Produced by Agoracom
      DENVILLE, N.J., March 11, 2009 (GLOBE NEWSWIRE) -- Lantis Laser Inc. (Other OTC:LLSR.PK - News) (http://www.lantislaser.com), announced today that its President & CEO, Mr. Stan Baron, can be heard all this week on the AOL Small Cap Show produced by AGORACOM Investor Relations. Mr. Baron will be discussing the company's latest developments including making the transition from the Pink Sheets to the OTCBB; the timing of commercial rollout of its OCT (Optical Coherence Tomography) and NIR (Near Infrared Transillumination) products, and how OCT/NIR will impact the dental industry
      Read Full Article
    13. UK-based OCT and nano-imaging firms attract investment for growth

      MARCH 9, 2009--Two British companies--NanoSight Ltd. (Amesbury, UK ) and Michelson Diagnostics (Kent, UK)--say that despite the economic downturn, they have raised investment money that will fuel growth for the coming year. Michelson is a developer of optical coherence tomography (OCT) devices, and NanoSight produces a family of instruments for the visualizing and sizing nanoparticles.
      Read Full Article
    14. Lantis Announces President's Investor Update On Strategic Achievements

      Lantis Laser Inc. (Pink Sheets:LLSR) (http://www.lantislaser.com), announced today that Stan Baron, President & CEO, released an official Update Letter to shareholders. Lantis is developing ground breaking light-based diagnostic imaging technology for application in dentistry.
      Read Full Article
    15. Imalux® Corporation and Preventive Oncology International®, Inc. Differentiate Grades of Pre-Invasive Cervical Dysplasia with Niris Optical Coherence Tomography Imaging System

      Imalux® Corporation and Preventive Oncology International®, Inc. Differentiate Grades of Pre-Invasive Cervical Dysplasia with Niris Optical Coherence Tomography Imaging System

      Imalux Corporation and Preventive Oncology International, Inc. (POI) conducted two studies to determine the diagnostic efficacy of “real time” Optical Coherence Tomography (OCT). The first study was held in December 2007 and the second in April 2008. Both IRB-approved studies took place in China in partnership with the Peking University Shenzhen Hospital and the Renmin Hospital in Buyi-Miao Autonomous District of Guizhou Province. Two thousand (2000) women participated in the studies and approximately two thousand eight hundred (2,800) OCT images were taken and were compared to diagnostic impression and pathologic findings to determine the accuracy of OCT. The studies ...

      Read Full Article
    16. Pioneering technology can detect glaucoma

      There are only about 30 OCT machines across the country and waiting for a hospital appointment to use the machine can be time-consuming. The machine can also detect retinal detachments, circulation disorders and even signs of diabetes. A session on the OCT and Optomap machines is not part of a routine eye test but is sometimes recommended by opticians if there is a particular concern.
      Read Full Article
    17. Volcano Corporation Announces Webcast of February 25th Analyst Day

      SAN DIEGO, Feb. 20 /- Volcano Corporation (Nasdaq: VOLC ), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, will hold its 2009 Analyst Day on Wednesday, February 25, at the NASDAQ MarketSite in New York City. The webcast will begin at 10 a.m., Eastern Standard Time (7 a.m., Pac...
      Read Full Article
    18. Topcon 3-D Measurement Software Granted FDA Clearance

      Topcon Medical Systems, Inc. (Paramus, NJ), has received FDA clearance for the enhanced 3D OCT-1000 TrueMap Measurement Software as an addition to the previously cleared 3D OCT-1000 Optical Coherence Tomography System, according to a company news release. The software allows users to view four layers of the retina, including the inner limiting membrane, the photoreceptor inner and outer segment junction, retinal pigment epithelium, and Bruch's membrane. In addition, the software is compatible with the Stratus 1 OCT system (Carl Zeiss Meditec, Dublin, CA). The cost of the 3D OCT-1000 TrueMap Measurement Software is included in the cost of the ...
      Read Full Article
    19. Volcano Reports Full Year Revenues Increase 31 Percent

      FOURTH QUARTER REVENUES INCREASE 23 PERCENT SAN DIEGO, Feb. 17 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today reported that revenues for the full year 2008 increased 31 percent over full year 2007 and that revenues for the fourth quarter of 2008 increased 23 percent over revenues in the fourth quarter of 2007. For the year ended December
      Read Full Article
    20. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast

      SAN DIEGO, Feb. 6 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today announced that it will report is operating results for the fourth quarter and all of fiscal 2008 on Tuesday, February 17. The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 2 p.m., Pacific Stan
      Read Full Article
    21. Michelson Diagnostics issues preliminary specs for clinical handheld OCT probe

      Michelson Diagnostics issues preliminary specs for clinical handheld OCT probe
      JANUARY 26, 2009--Michelson Diagnostics (London, UK) has issued a preliminary specification for its clinical optical coherence tomography (OCT) probe and processing system, which the company demonstrated this past weekend at the SPIE's BiOS exhibition. The system, named Vivosight, will be available with two probe versions--one with X-Y scanning to enable 3D mapping of flat tissue such as skin, and the other with a rigid endoscope for internal applications.
      Read Full Article
    22. Michelson Diagnostics singled out as high-growth company

      Uk-based Michelson Diagnostics has been singled out as a company with high growth potential by two leading investor organisations. The European Tech Tour Association held its first MedTech Tour Summit in November 2008 to bring together Europe’s most innovative medical technology companies with leading venture capitalists and leading industry professionals. Michelson Diagnostics was one of just 24 start-up companies selected from 240 candidates, by an expert panel of investors, to present at the event. The MedTech Tour Summit attracted big name US investors, including Medtronic, Johnson & Johnson, Edwards Lifesciences, and Boston Scientific, as well as US venture capitalists from ...
      Read Full Article
    1081-1104 of 1187 « 1 2 ... 43 44 45 46 47 48 49 50 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Popular Articles

  3. OCT Companies in the News

    1. (2 articles) PhotoniCare
    2. (1 articles) Cylite